M. L. Simoons

2.9k total citations · 1 hit paper
45 papers, 2.0k citations indexed

About

M. L. Simoons is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. L. Simoons has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. L. Simoons's work include Acute Myocardial Infarction Research (12 papers), Cardiac Imaging and Diagnostics (8 papers) and Coronary Interventions and Diagnostics (7 papers). M. L. Simoons is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Cardiac Imaging and Diagnostics (8 papers) and Coronary Interventions and Diagnostics (7 papers). M. L. Simoons collaborates with scholars based in Netherlands, Belgium and United Kingdom. M. L. Simoons's co-authors include Keith A.A. Fox, Gilles R. Dagenais, Janice Pogue, Salim Yusuf, Eric Boersma, Máximo Rivero‐Ayerza, Héctor M. García‐García, Luc Jordaens, Dominic A.M.J. Theuns and Aggie H.M.M. Balk and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

M. L. Simoons

43 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

1988 474 citations M. L. Simoons The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. L. Simoons Netherlands	17	1.6k	823	509	197	121	45	2.0k
Lynn H. Woodlief United States	15	2.0k 1.2×	801 1.0×	831 1.6×	279 1.4×	46 0.4×	26	2.4k
A.T. Marcel Gosselink Netherlands	29	2.6k 1.6×	1.1k 1.4×	861 1.7×	159 0.8×	128 1.1×	90	2.9k
Carolyn H. McCabe United States	16	1.1k 0.7×	420 0.5×	396 0.8×	152 0.8×	72 0.6×	21	1.3k
Chong Jin Kim South Korea	25	1.8k 1.1×	1.1k 1.4×	936 1.8×	69 0.4×	154 1.3×	132	2.3k
Charles Lazzam Canada	15	1.2k 0.7×	948 1.2×	461 0.9×	146 0.7×	25 0.2×	27	1.5k
Michel R. Le May Canada	25	1.7k 1.0×	885 1.1×	471 0.9×	213 1.1×	77 0.6×	61	2.1k
Lorelei Grines United States	22	1.7k 1.1×	960 1.2×	775 1.5×	79 0.4×	41 0.3×	31	1.9k
Frank Vermeer Netherlands	19	2.1k 1.3×	941 1.1×	1.0k 2.0×	288 1.5×	23 0.2×	50	2.5k
Marek Gierlotka Poland	26	1.8k 1.1×	1.0k 1.2×	660 1.3×	105 0.5×	162 1.3×	216	2.6k
RM Califf United States	20	1.3k 0.8×	632 0.8×	321 0.6×	280 1.4×	23 0.2×	40	1.6k

Countries citing papers authored by M. L. Simoons

Since Specialization

Citations

This map shows the geographic impact of M. L. Simoons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Simoons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Simoons more than expected).

Fields of papers citing papers by M. L. Simoons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Simoons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Simoons. The network helps show where M. L. Simoons may publish in the future.

Co-authorship network of co-authors of M. L. Simoons

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Simoons. A scholar is included among the top collaborators of M. L. Simoons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Simoons. M. L. Simoons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groot, Natasja M.S. de, et al.. (2010). Dronedarone in patients with atrial fibrillation. Netherlands Heart Journal. 18(7). 370–373. 5 indexed citations

Lenzen, Mattie, Wilma J.M. Scholte op Reimer, Susanne S. Pedersen, et al.. (2006). The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation. Heart. 93(3). 339–344. 42 indexed citations

Briggs, Andrew, Borislava Mihaylova, Mark Sculpher, et al.. (2006). Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart. 93(9). 1081–1086. 48 indexed citations

Dagenais, Gilles R., Janice Pogue, Keith A.A. Fox, M. L. Simoons, & Salim Yusuf. (2006). Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. The Lancet. 368(9535). 581–588. 337 indexed citations

Ottervanger, Jan Paul, Paul W. Armstrong, Eric Boersma, et al.. (2004). Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. European Heart Journal. 25(17). 1494–1501. 29 indexed citations

Janknegt, R., et al.. (1999). HMG-coenzym a reductase inhibitors: drugselection by means of the soja method. European Journal of Hospital Pharmacy. 5. 29–45. 1 indexed citations

Ronner, Eelko, et al.. (1998). Combined therapy with streptokinase and integrilin. Journal of the American College of Cardiology. 31. 191–191. 25 indexed citations

Hamm, Christian W., et al.. (1998). Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. Journal of the American College of Cardiology. 31. 185–185. 23 indexed citations

Harrington, RA, Carmelo Graffagnino, Mark J. Alberts, et al.. (1998). Comparison of stroke rates in patients with acute coronary syndromes and patients with acute myocardial infarction. Journal of the American College of Cardiology. 31. 406–406.

10.

Lincoff, A. Michael, et al.. (1998). Complementarity of stenting and abciximab for percutaneous coronary intervention. Journal of the American College of Cardiology. 31. 54–54. 5 indexed citations

11.

Liem, Aylee, Felix Zijlstra, Henrik Olsson, et al.. (1997). First results of abciximab (ReoPro) in the treatment of acute myocardial infarction and primary PTCA: the GRAPE pilot study. Circulation. 96. 474–474. 4 indexed citations

12.

Boersma, Eric & M. L. Simoons. (1997). Reperfusion strategies in acute myocardial infarction. European Heart Journal. 18(11). 1703–1711. 18 indexed citations

13.

Balk, Aggie H.M.M., Pieter E. Zondervan, Peter van der Meer, et al.. (1997). Effect of adopting a new histological grading system of acute rejection after heart transplantation. Heart. 78(6). 603–607. 8 indexed citations

14.

Simoons, M. L., et al.. (1995). Ridogrel as an adjunct to thrombolysis in acute myocardial infarction. International Journal of Cardiology. 52(2). 125–134. 11 indexed citations

15.

Balk, Aggie H.M.M., et al.. (1993). Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam heart transplant program experience. Infection. 21(4). 195–200. 16 indexed citations

16.

Balk, Aggie H.M.M., K Meeter, M. L. Simoons, et al.. (1992). Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study. PubMed. 5 Suppl 1. 476–479. 4 indexed citations

17.

Balk, Aggie H.M.M., M. L. Simoons, K Meeter, et al.. (1992). Too early for cardiac transplantation—the right decision?. European Heart Journal. 13(10). 1339–1344. 3 indexed citations

18.

Balk, Aggie H.M.M., K Meeter, M. L. Simoons, et al.. (1992). Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study. Transplant International. 5. S476–S479. 5 indexed citations

19.

Hendriks, Giel, G. M. Th. Schreuder, G J Wenting, et al.. (1988). Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.. BMJ. 297(6653). 888–890. 4 indexed citations

20.

Tijssen, J. G. P., M. L. Simoons, & J Lubsen. (1987). Review of other trials. European Heart Journal. 8(suppl H). 87–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact